opportunity analysis

Trinity Biotech

Company Overview

Trinity Biotech (Nasdaq: TRIB) develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and blood coagulation disorders, and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For more information on Trinity Biotech, please visit the company's website at http://www.trinitybiotech.com/.


Trinity BiotechTrinity Biotech